ENGLISH: Why Biotech is Becoming Exciting for Investors Again
Biotech investor BB Biotech delivered a strong performance in 2025, benefiting significantly from a resurgence of investor interest in the sector. In this podcast, Christian Koch, Head of the BB Biotech Team, discusses why the fundamentals in the biotech market are improving, why acquisitions are once again becoming a key value driver—and what clinical breakthroughs and investment opportunities he expects to see in the coming years.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.